Filing Flows › Dare Bioscience (DARE) › R&D spending
Dare Bioscience (DARE) R&D spending by quarter
Dare Bioscience's R&D spending was $242K in Q2 2026 (second quarter 2026), -63% from Q1 2026. Over the last 5 quarters it ranged from $242K (Q2 2026) to $2.3M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $242K | -63% | — |
| Q1 2026 | $660K | +6% | -71% |
| Q4 2025 | $622K | -47% | — |
| Q3 2025 | $1.2M | -49% | — |
| Q1 2025 | $2.3M | — | — |
Q2 2026 at a glance
Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Dare Bioscience's R&D spending?
Dare Bioscience's R&D spending was $242K in Q2 2026 (second quarter 2026), -63% from Q1 2026.
How has Dare Bioscience's R&D spending changed?
Over the last 5 quarters it ranged from $242K (Q2 2026) to $2.3M (Q1 2025).